Showing results (961-970 of 2,595) with videos related to

Sort By:
Pageof 260
The Australasian Journal of Dermatology|January 18, 2023
Conditional survival in patients with stage IB-IIIA melanoma undergoing sentinel node biopsy in Queensland: A longitudinal studyAlexander James Tedman, Upekha E Liyanage, Sharene Chong, et al.
The Australasian Journal of Dermatology|December 24, 2022
Penicillamine-induced degenerative dermopathy in a patient with Wilson's diseaseYuting Chen, Yangyang Qiu, Meiqing Chen, et al.
The Australasian Journal of Dermatology|December 14, 2022
Bullous pemphigoid associated with anti-programmed cell death protein 1 and anti-programmed cell death ligand 1 therapy: A case series of 13 patientsJenny S W Yun, On Bon Chan, Michelle Goh, et al.
The Australasian Journal of Dermatology|November 19, 2019
A clinical, pathological and immunohistochemical series of 9 cases of primary cutaneous apocrine carcinomas of the head and neckFrancesca Portelli, Lorenzo Salvati, Elisabetta Projetto, et al.
The Australasian Journal of Dermatology|November 7, 2019
Impact on quality of life in patients with dermatophytosisSabha Mushtaq, Nafis Faizi, Syed S Amin, et al.
The Australasian Journal of Dermatology|December 5, 2020
Knowledge and attitudes of Australian dermatologists towards sentinel lymph node biopsy for melanoma: a mixed methods studyAndrea L Smith, Caroline G Watts, Samuel Robinson, et al.
The Australasian Journal of Dermatology|January 2, 2021
Cutaneous T-cell lymphoma mimicking palmoplantar pustular psoriasis: A rare variantEmma Hignett, Lucia Seminario-Vidal, Kenneth Shulman, et al.
The Australasian Journal of Dermatology|January 4, 2021
Clobetasol propionate 0.05% under occlusion for alopecia areata: Clinical effect and influence on intraocular pressureTomoko Nomiyama, Norito Katoh
The Australasian Journal of Dermatology|May 6, 2022
Sensitivity of two Australian melanoma risk tools to identify high-risk individuals among people presenting with their first primary melanomaKatrina Tan, Serigne N Lo, Anne E Cust, et al.
The Australasian Journal of Dermatology|July 27, 2021
A case of omalizumab as a successful treatment for telangiectasia macularis eruptiva perstansAlexandra Maria Mortimore, Ramez Barsoum, Duncan Lambie, et al.
Pageof 260